GlobalData on MSN15d
FDA approves Zydus’ Phase IIb trial of Usnoflast for ALS treatment
The US Food and Drug Administration (FDA) has granted approval for Zydus Lifesciences to proceed with a randomised Phase IIb ...
ALS News Today11d
Zydus cleared to begin US trial of oral therapy usnoflast for ALS
Zydus received FDA approval to conduct a Phase 2b trial testing usnoflast, its oral therapy for ALS, in 210 patients.
Medscape2d
AstraZeneca Sues Generic Drugmakers, Claims Cancer Drug Patent Violations
Natco Pharma, and Zydus Pharmaceuticals are planning to make and sell generic versions of Lynparza, which infringes on a new patent that covers the active pharmaceutical ingredient, olaparib.
devdiscourse13d
Zydus Strides Forward with Orphan Drug for ALS
Zydus Lifesciences announced that Usnoflast, a treatment for amyotrophic lateral sclerosis (ALS), has received Orphan Drug Designation from the US FDA. This designation supports the development of ...
Pharmabiz28d
Zydus enters agreement with CVS Caremark to add Zituvio, Zituvimet and Zituvimet XR to its template formulary
Punit Patel, president & CEO Zydus Pharmaceuticals USA Inc., commented on the development, saying, "We are proud to have partnered with CVS Caremark, one of the most patient-centric healthcare ...
Zee Business28d
Zydus Lifesciences joins hands with CVS Caremark for diabetes drugs template formulary
Zydus Pharmaceuticals USA Inc President & CEO Punit Patel said the relationship is a strong validation of Zydus' strategic investments in the new drug applications portfolio. It "will set the way for ...